ZBRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. ZBRA is in a short-to-medium term downtrend (bearish moving-average stack and weakening MACD), sitting just above near-term support (~234). While options positioning is bullish-leaning (low put/call ratios) and hedge funds show strong recent buying, the tape is still bearish and the next clear catalyst is earnings (2026-02-12 pre-market), which adds near-term event risk. For an impatient buyer who doesn’t want to wait for a cleaner entry/confirmation, the odds favor holding off rather than buying immediately.
Trend/price action: Bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), signaling persistent downside momentum. MACD histogram (-1.553) is below zero and expanding negatively, confirming the downtrend is still strengthening rather than stabilizing. Momentum: RSI(6)=31.6 is near oversold territory, which can support a tactical bounce, but it is not a reversal signal on its own given the bearish MACD/MA structure. Levels: Pivot 244.10 is the key reclaim level; price below this keeps bears in control. Immediate support S1 ~234.18 (price ~239.24 close; option snapshot price ~234.98 suggests testing this zone). If S1 breaks, next support S2 ~228.05. Upside resistance levels: 254.03 then 260.16. Pattern/stat bias: Similar-pattern model suggests ~-1.23% next week, +2.57% next month (near-term weak, medium-term modest rebound).
Intellectia Proprietary Trading Signals
Options positioning leans bullish (low put/call ratios), supporting the case for a near-term oversold bounce.
RSI near oversold can fuel reflex rallies if support holds.
Hedge fund activity indicates aggressive recent accumulation (reported large quarter-over-quarter increase), which can provide longer-horizon support.
Upcoming earnings (2026-02-12 pre-market) could act as a catalyst if results/guide beat expectations (Street EPS est. 3.52).
No supportive near-term news flow in the last week (no positive catalysts currently in headlines).
with elevated IV; disappointment could accelerate downside.
Latest quarter: 2025/Q3. Growth: Revenue $1.32B, +5.18% YoY (modest top-line growth). Profitability: Net income $101M, -26.28% YoY; EPS $1.97, -25.38% YoY. Margins: Gross margin 46.14%, down -0.84 YoY. Takeaway: Sales are growing, but profitability and EPS are contracting meaningfully—this fundamental mix weakens near-term confidence and helps explain the bearish technical posture.
Recent change: On 2025-12-18, Truist (Jamie Cook) lowered price target to $291 from $331 and maintained a Hold rating. Trend implication: Price target cut + reiterated Hold suggests analysts are cautious and see limited near-term upside vs prior expectations. Wall Street pros/cons view: Pros: Exposure to industrial/automation themes; potential demand stabilization/green shoots referenced in broader multi-industry commentary. Cons: Caution about demand/backlog durability and investors looking for signs of peak demand; the PT cut reinforces a more conservative outlook.
